A teal tablet, closed dropper bottle and shallow preparation dish.

Drug behavior & delivery

Formulation

Also found as: formulations · preparation

In plain language

The prepared form of a substance used in a study. The RGN-259 trial, for example, evaluates thymosin β4 in an ophthalmic solution.[1]

Source check: 2026-10-04 · Editorial method

How the research uses this term

The trial's preparation was delivered to the eye in patients with neurotrophic keratopathy. Its outcomes included healing of a persistent defect on the corneal surface and ocular symptoms.[1]

Reading the evidence

The study therefore concerns a particular molecule, eye-drop preparation, route and condition. It does not test a commercially named TB-500 injection for tendon injury.[1]

Used in our guides

Continue reading where this term appears.

References

Definitions and explanations are paraphrased. The source locations below identify the supporting passages and methods.

  1. 0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical TrialPrimary research · Human randomized trial · 2023DOI: 10.3390/ijms24010554

    Source locations: Abstract; Materials and Methods; Materials and Methods; Results.

    Review status · Pending
    Source packet file

    0_1_RGN_259_Thymosin_4_Ophthalmic_Solution_Promotes_Healing_and_Improves_36613994_PMC9820614.pdf